CIRAX | HRLSX | CIRAX / HRLSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 15 years | - |
Gain YTD | 4.685 | 3.748 | 125% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 111B | 68M | 163,235% |
Annual Yield % from dividends | 3.25 | 3.96 | 82% |
Returns for 1 year | 10.78 | 3.95 | 273% |
Returns for 3 years | 18.20 | 4.43 | 411% |
Returns for 5 years | 40.66 | 39.75 | 102% |
Returns for 10 years | 69.36 | 32.76 | 212% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DTGCX | 29.53 | N/A | N/A |
BNY Mellon Technology Growth C | |||
RPGEX | 42.87 | N/A | N/A |
T. Rowe Price Global Growth Stock | |||
GSFPX | 16.97 | N/A | N/A |
Goldman Sachs US Eq Div and Premium P | |||
DIEAX | 38.87 | -0.04 | -0.10% |
BNY Mellon International Core Equity A | |||
CIRCX | 72.38 | -0.64 | -0.88% |
American Funds Capital Income Bldr 529C |